Adaptation‐Proof SARS‐CoV‐2 Vaccine Design
Sign Up to like & getrecommendations! Published in 2022 at "Advanced Functional Materials"
DOI: 10.1002/adfm.202206055
Abstract: Abstract Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) surface spike glycoprotein—a major antibody target—is critical for virus entry via engagement of human angiotensin‐converting enzyme 2 (ACE2) receptor. Despite successes with existing vaccines and therapies that… read more here.
Keywords: vaccine design; epitope scaffolds; sars cov; spike protein ... See more keywords